Exhibit 10.2


 


THIS WARRANT AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAW, AND MAY NOT BE OFFERED FOR SALE, SOLD OR TRANSFERRED UNLESS A REGISTRATION STATEMENT UNDER SUCH ACT
AND APPLICABLE STATE SECURITIES LAWS SHALL BE EFFECTIVE WITH RESPECT THERETO, OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES LAWS IS AVAILABLE IN CONNECTION WITH SUCH OFFER, SALE OR TRANSFER.


 


Champions Oncology, Inc.


 


WARRANT


 


	Warrant No. [•]	 	Dated: March 13, 2015


 


Champions Oncology, Inc., a Delaware corporation
(the “Company”), hereby certifies that, for value received, [Name_of_Investor] or its registered assigns (the
“Holder”), is entitled to purchase from the Company up to a total of [•] fully paid and non-assessable
shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (each such share, a
“Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to
$0.48 per share (subject to appropriate adjustment provided in Section 9 herein, the “Exercise Price”), at any
time after the date hereof (the “Initial Exercise Date”) and through and including the date that is sixty (60)
months from the date hereof (or, if such date is not a Business Day, on the Business Day immediately following such date) (the
“Expiration Date”), subject to the following terms and conditions. This Warrant (this “Warrant”)
is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of March 11, 2015,
by and among the Company and the Investors identified therein (the “Purchase Agreement”). All such warrants
are referred to herein, collectively, as the “Warrants.”


 


1. Definitions. In addition to the terms
defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms
in the Purchase Agreement.


 


2. Registration of Warrant. The Company
shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of record of this
Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.


 


3. Transfers and Registration of Transfers.
The Holder may sell, transfer, assign, pledge or otherwise dispose of this Warrant, in whole or in part, as long as such sale or
other disposition is made pursuant to an effective registration statement or an exemption from the registration requirements of
the Securities Act, in which case the Holder shall provide an opinion of counsel reasonably acceptable to the Company that such
transfer or other disposition is so exempt. Upon such transfer or other disposition (other than a pledge), the Holder shall deliver
this Warrant to the Company together with a written notice to the Company, substantially in the form of the Transfer Notice attached
hereto as Exhibit A (the “Transfer Notice”), indicating the person or persons to whom this Warrant shall be
transferred and, if less than all of this Warrant is transferred, the number of Warrant Shares to be covered by the part of this
Warrant to be transferred to each such person. The Company shall register the transfer of any portion of this Warrant in the Warrant
Register, upon surrender of this Warrant, with the Transfer Notice duly completed and signed, to the Company at its address specified
in the Purchase Agreement. Within three (3) Business Days of any such registration of transfer, a new warrant to purchase Common
Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the portion
of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant
not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof
shall be deemed the acceptance by such transferee of all of the rights and obligations of a holder of a Warrant.


 




    	 



    	 



    

 


4. Exercise and Duration of Warrants.


 


(a) This Warrant shall be exercisable by the
registered Holder at any time and from time to time on or after the Initial Exercise Date and including the Expiration Date, as
to all or any part of the Warrant Shares covered hereby. At 6:00 p.m., New York City time on the Expiration Date, the portion of
this Warrant not exercised prior thereto shall be and become void and of no value.


 


(b) A Holder may exercise this Warrant by
delivering to the Company (i) an exercise notice, in the form attached hereto (the “Exercise Notice”),
appropriately completed and duly signed, and (ii) either (A) in the case of a cash exercise in immediately available funds
(“Cash Exercise”), payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is
being exercised, or (B) in the event of a Cashless Exercise (as defined below), no payment is required; and the date such items
are delivered to the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.”
The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery
of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing
the right to purchase the remaining number of Warrant Shares.


 


(c) In the case of a dispute between the Company
and the Holder as to the calculation of the Exercise Price or the number of Warrant Shares issuable hereunder (including, without
limitation, the calculation of any adjustment pursuant to Section 9 below), the Company shall issue to the Holder the number of
Warrant Shares that are not disputed within the time periods specified in Section 5 below and shall submit the disputed calculations
to a certified public accounting firm of national recognition (other than the Company’s regularly retained accountants) within
three (3) Business Days following the Company’s receipt of the Holder’s Exercise Notice. The Company shall cause such
accountant to calculate the Exercise Price and/or the number of Warrant Shares issuable hereunder and to notify the Company and
the Holder of the results in writing no later than three (3) Business Days following the day on which such accountant received
the disputed calculations (the “Dispute Procedure”). Such accountant’s calculation shall be deemed conclusive
absent manifest error. The fees of any such accountant shall be borne by the party whose calculations were most at variance with
those of such accountant.


 




    	2



    	 



    

 


5. Delivery of Warrant Shares.


 


(a) Upon exercise of this Warrant, the Company
shall, (A) in the case of a Cash Exercise, no later than the close of business on the later to occur of (i) the third (3rd) Business
Day following the Exercise Date set forth in such Exercise Notice and (ii) such later date on which the Company shall have received
payment of the Exercise Price, (B) in the case of a Cashless Exercise, no later than the close of business on the third (3rd) Business
Day following the Exercise Date set forth in such Exercise Notice, and (C) with respect to Warrant Shares that are the subject
of a Dispute Procedure, the close of business on the third (3rd) Business Day following the determination made pursuant to Section
4(c) (each of the dates specified in (A), (B) or (C) being referred to as a “Delivery Date”), the Company shall
promptly issue or cause to be issued and cause to be delivered to or upon the written order of the Holder and in such name or names
as the Holder may designate, a certificate for the Warrant Shares issuable upon such exercise, free of restrictive legends unless
a legend is required to be placed on the certificate pursuant to Section 2.1(f) of the Purchase Agreement. The Holder, or
any Person so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant
Shares as of the Exercise Date. The Company shall, provided that the Transfer Agent is participating in The Depository Trust Company
(“DTC”) Fast Automated Securities Transfer Program (“FAST”), use its commercially reasonable
efforts to credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s
or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system (“DWAC”);
provided further, that the Holder provides the Company the reasonably necessary details to effect the foregoing DWAC delivery.
In the event that the Transfer Agent is not a participant in FAST, or if the Warrant Shares are not otherwise eligible for delivery
through FAST, or if the Holder so specifies in an Exercise Notice or otherwise in writing on or before the Exercise Date, the Company
shall effect delivery of Warrant Shares by delivering to the Holder or its nominee physical certificates representing such Warrant
Shares, no later than the close of business on such Delivery Date. Warrant Shares delivered to the Holder shall not contain any
restrictive legend as long as such Warrant Shares have been resold (as certified in writing by the Holder to the Company (x) pursuant
to an effective Registration Statement (as defined in the 2015 Amended and Restated Registration Rights Agreement) or (y) pursuant
to Rule 144 under the Securities Act.


 


(b) This Warrant is exercisable, either in
its entirety or, from time to time, for a portion of the number of Warrant Shares. Upon surrender of this Warrant following one
or more partial exercises, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to
purchase the remaining number of Warrant Shares; provided, however, that the Holder shall be entitled to exercise all or
any portion of such New Warrant at any time following the time at which this Warrant is exercised, regardless of whether the Company
has actually issued such New Warrant or delivered to the Holder a certificate therefor.


 


(c) The Company’s obligations to issue
and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction
by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against
any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach
or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law
by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the
Company to the Holder in connection with the issuance of Warrant Shares.


 


(d) In the event that the Company fails for
any reason to deliver to the Holder the number of Warrant Shares specified in the applicable Exercise Notice on or before the Delivery
Date therefor (an “Exercise Default”), the Company shall pay to the Holder payments (“Exercise Default
Payments”) in the amount of (i) (N/365) multiplied by (ii) the aggregate Exercise Price of the Warrant Shares
which are the subject of such Exercise Default multiplied by (iii) the lower of twelve percent (12%) per annum and the maximum
rate permitted by applicable law (the “Default Interest Rate”), where “N” equals the number of days
elapsed between the original Delivery Date of such Warrant Shares and the date on which all of such Warrant Shares are issued and
delivered to the Holder. Cash amounts payable hereunder shall be paid on or before the fifth (5th) Business Day of each calendar
month following the calendar month in which such amount has accrued.


 




    	3



    	 



    

 


(e) In the event of an Exercise Default, the
Holder may, upon written notice to the Company, regain on the date of such notice the rights of the Holder under the exercised
portion of this Warrant that is the subject of such Exercise Default. In such event, the Holder shall retain all of the Holder’s
rights and remedies with respect to the Company’s failure to deliver such Warrant Shares (including without limitation the
right to receive the cash payments specified in Section 5(d) above); provided, however, that such cash payments shall cease
to accrue effective as of the date of such notice.


 


(f) The Holder’s rights and remedies
hereunder are cumulative, and no right or remedy is exclusive of any other. In addition to the amounts specified herein, the Holder
shall have the right to pursue all other remedies available to it at law or in equity (including, without limitation, a decree
of specific performance and/or injunctive relief). Nothing herein shall limit the Holder’s right to pursue actual damages
for the Company’s failure to issue and deliver Warrant Shares on the applicable Delivery Date (including, without limitation,
damages relating to any purchase of Common Stock by the Holder to make delivery on a sale effected in anticipation of receiving
Warrant Shares upon exercise, such damages to be in an amount equal to (A) the aggregate amount paid by the Holder for the Common
Stock so purchased minus (B) the aggregate amount of net proceeds, if any, received by the Holder from the sale of
the Warrant Shares issued by the Company pursuant to such exercise).


 


6. Charges, Taxes and Expenses. Issuance
and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall be made without charge to the Holder
for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the issuance
of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not
be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates for
Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for all other tax liability
that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.


 


7. Replacement of Warrant. If this Warrant
is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon
cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction and customary and reasonable bond or indemnity, if requested. Applicants
for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such
other reasonable third-party costs as the Company may prescribe.


 


8. Reservation of Warrant Shares. The
Company covenants that it will at all times reserve and keep available out of the aggregate of its authorized but unissued and
otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant
as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise of this entire Warrant,
free from preemptive rights or any other contingent purchase rights of persons other than the Holder (after giving effect to the
adjustments and restrictions of Section 9, if any). The Company covenants that all Warrant Shares so issuable and deliverable
shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly
authorized, issued and fully paid and nonassessable. The Company will take all such action as may be necessary to assure that such
shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of any securities exchange or automated quotation system upon which the Common Stock may be listed.


 


9. Certain Adjustments. The Exercise
Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth
in this Section 9.


 




    	4



    	 



    

 


(a) Stock Dividends and Splits. If
the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and
of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number
of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 9(a) shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.


 


(b) Pro Rata Distributions. If the
Company, at any time while this Warrant is outstanding, distributes to holders of Common Stock (i) evidences of its indebtedness,
(ii) any security (other than a distribution of Common Stock covered by the preceding paragraph), (iii) rights or warrants
to subscribe for or purchase any security, or (iv) cash or any other asset, or rights to acquire such assets, as a partial
liquidating dividend or otherwise, including without limitation any dividend or distribution to the Company’s stockholders
in shares (or rights to acquire shares) of capital stock of a subsidiary (in each case, “Distributed Property”),
then in each such case the Holder shall be entitled, upon exercise of this Warrant for the purchase of any or all of the Warrant
Shares, to receive the amount of Distributed Property which would have been payable to the Holder had such Holder been the holder
of such Warrant Shares on the record date for the determination of stockholders entitled to such Distributed Property. The Company
will at all times set aside in escrow and keep available for distribution to such holder upon exercise of this Warrant a portion
of the Distributed Property to satisfy the distribution to which such Holder is entitled pursuant to the preceding sentence. The
Company shall deliver written notice of such distribution of Distributed Property (a “Distribution Notice”)
to the Holder at least thirty (30) days prior to the earlier to occur of (i) the record date for determining stockholders
entitled to such Distribution and (ii) the date on which such distribution is made (the “Distribution Date”).
In the Distribution Notice to a Holder, the Company must indicate whether the Company has elected (A) to deliver to such Holder
the same amount and type of Distributed Property as though the Holder were a holder on the determination date therefor of a number
of shares of Common Stock into which the this Warrant is exercisable as of such determination date (such number of shares to be
determined at the Exercise Price then in effect and without giving effect to any limitations on such exercise) or (B) to reduce
the Exercise Price as of the determination date therefor by an amount equal to the fair market value of the Distributed Property
divided by the number of shares of Common Stock as to which such distribution is to be made, such fair market value to be
reasonably determined in good faith by the independent members of the Company’s Board of Directors. If the Company does not
notify the Holders of its election pursuant to the preceding sentence within two (2) Business Days following the date on which
the Company publicly announces a distribution, the Company shall be deemed to have elected clause (A) of the preceding sentence.


 




    	5



    	 



    

 


(c)Fundamental Transactions. If,
at any time while this Warrant is outstanding, (i) the Company effects any merger or consolidation of the Company with or
into another Person, (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related
transactions, (iii) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Stock owning more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the Person or Persons making or affiliated with the Persons making the tender or exchange offer) tender or exchange
their shares for other securities, cash or property, or (iv) the Company effects any reclassification of the Common Stock
or any compulsory share exchange or any other transaction pursuant to which the Common Stock is effectively converted into or exchanged
for other securities, cash or property of the Company or another entity (other than as a result of a subdivision or combination
of shares of Common Stock covered by Section 9(a) above) (in any such case, a “Fundamental Transaction”),
then the Holder shall have the right thereafter to receive, upon exercise of this Warrant, on a per share basis, the same amount
and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction
if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon
exercise of this Warrant (the “Alternate Consideration”). The aggregate Exercise Price for this Warrant will
not be affected by any such Fundamental Transaction, but the Company shall apportion such aggregate Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. At the Holder’s request, any successor to the Company or surviving entity in such
Fundamental Transaction shall issue to the Holder a New Warrant consistent with the foregoing provisions and evidencing the Holder’s
right to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof. The terms of any agreement
pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to
comply with the provisions of this paragraph (c) and insuring that the Warrant (or any such replacement security) will be
similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.


 


(e) Number of Warrant Shares. Simultaneously
with any adjustment to the Exercise Price pursuant to Section 9(a), the number of Warrant Shares that may be purchased upon
exercise of this Warrant shall be adjusted proportionately, so that after such adjustment the aggregate Exercise Price payable
hereunder for the increased or decreased number of Warrant Shares, as applicable, shall be the same as the aggregate Exercise Price
in effect immediately prior to such adjustment. In the event that at any time, as a result of an adjustment made pursuant to this
Section 9, the Holder of this Warrant shall, upon exercise of this Warrant, become entitled to receive securities or assets (other
than Common Stock) then, wherever appropriate, all references herein to shares of Common Stock shall be deemed to refer to and
include such shares and/or other securities or assets; and thereafter the number of such shares and/or other securities or assets
shall be subject to adjustment from time to time in a manner and upon terms as nearly equivalent as practicable to the provisions
of this Section 9. Any adjustment made herein pursuant to Section 9(a) that results in a decrease in the Exercise Price shall also
effect a proportional increase in the number of shares of Common Stock into which this Warrant is exercisable.


 


(f) Calculations. The number of shares
of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and
the disposition of any such shares shall be considered an issue or sale of Common Stock.


 




    	6



    	 



    

 


(g) Notice of Adjustments. Upon the
occurrence of each adjustment pursuant to this Section 9 or any change in the number or type of stock, securities and/or other
property issuable upon exercise of this Warrant, the Company at its expense will promptly compute such adjustment or change in
accordance with the terms of this Warrant and prepare a certificate (an “Adjustment Notice”) setting forth such
adjustment or change, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other
securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments
or changes and showing in detail the facts upon which such adjustment or change is based and, on or before the time that it delivers
an Adjustment Notice, publicly disclose the contents thereof. Upon written request, the Company will promptly deliver a copy of
each such Adjustment Notice to the Holder and to the Transfer Agent. The failure of the Company to deliver an Adjustment Notice
shall not affect the validity of any such adjustment.


 


(h) Notice of Corporate Events. If
the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common
Stock, including without limitation any granting of rights or warrants to subscribe for or purchase any capital stock of the Company
or any Subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for
any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the
Company, then the Company shall deliver to the Holder a notice describing the material terms and conditions of such transaction,
at least ten (10) Business Days prior to the applicable record or effective date on which a Person would need to hold Common
Stock in order to participate in or vote with respect to such transaction (or if no such date is applicable, at least ten (10)
Business Days prior to the closing or effectiveness of the transaction), and the Company will take all steps reasonably necessary
in order to insure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so as to participate
in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any defect
therein shall not affect the validity of the corporate action required to be described in such notice. The notice requirements
in this Section 9(h) shall be in addition to the requirements for notice in connection with Distributed Property as set forth in
Section 9(b) hereof.


 


10. Payment of Exercise Price. The Holder
shall pay the Exercise Price (i) through a Cash Exercise or (ii) if an effective Registration Statement is not available
for the resale of all of the Warrant Shares issuable hereunder at the time an exercise notice, in the form attached hereto as Exhibit
B (the “Exercise Notice”), is delivered to the Company, through a “cashless exercise” (a “Cashless
Exercise”) in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows:


 


	 	 	 
	 	 	X = Y * [(A-B)/A]
	 	 
	where:	 	 
	 	 
	 	 	X = the number of Warrant Shares to be issued to the Holder.
	 	 
	 	 	Y = the number of Warrant Shares with respect to which this Warrant is being exercised.
	 	 
	 	 	A = the Market Price (as defined below) as of the Exercise Date.
	 	 
	 	 	B = the Exercise Price.


 




    	7



    	 



    

 


For purposes of Rule 144 promulgated under the Securities Act, it
is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have
been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this
Warrant was originally issued pursuant to the Purchase Agreement. “Market Price” shall mean for any date, the
price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a stock
exchange, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the stock
exchange on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)  the volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading
on the OTC Bulletin Board and if prices for the Common Stock are then reported in the “Pink Sheets” published by Pink
OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Investors of a majority in interest of the Shares then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


 


11. Fractional Shares. The Company shall
not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. If any fraction of a
Warrant Share would, except for the provisions of this Section 11, be issuable upon exercise of this Warrant, the Company shall,
in lieu of issuing any such fractional share, pay to the Holder an amount in cash equal to the product resulting from multiplying
such fraction by the Market Price as of the Exercise Date.


 


12. Notices. Any and all notices or
other communications or deliveries hereunder (including without limitation any Exercise Notice) shall be in writing and shall be
deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number specified in the Purchase Agreement prior to 6:30 p.m. (New York City time) on a Trading Day,
(ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the
facsimile number specified in the Purchase Agreement on a day that is not a Trading Day or later than 6:30 p.m. (New York City
time) on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight
courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for such
notices or communications shall be as set forth in the Purchase Agreement with respect to the Company and, with respect to the
Holder, the Holder’s last address as shown on the Warrant Register.


 


13. Warrant Agent. The Company shall
serve as warrant agent under this Warrant. Upon thirty (30) days’ notice to the Holder, the Company may appoint a new
warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from
any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any
new warrant agent transfers substantially all of its corporate trust or stockholder services business shall be a successor warrant
agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession
as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown
on the Warrant Register.


 




    	8



    	 



    

 


14. Limitation on Exercise.  


 


[(a) The Company shall not effect the exercise
of this Warrant, and the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such
exercise, such Person (together with such Person's affiliates) would beneficially own in excess of 9.99% (the "Maximum
Percentage") of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Person and its affiliates
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining,
unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act. For purposes of this Warrant, in
determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common
Stock as reflected in (1) the Company's most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with
the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other
notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any
time, upon the written or oral request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written
notice to the Company, the Holder may waive the provisions of this Section 14 or increase or decrease the Maximum Percentage to
any other percentage specified in such notice, but (i) any such waiver or increase will not be effective until the sixty-first
(61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the
Holder and not to any other holder of Warrants.


 


(b) The Company’s obligation to issue
shares of Common Stock in excess of any limitation referred to in this Section 14 shall be suspended (and shall not terminate or
expire notwithstanding any contrary provisions hereof) until such time, if any, as such shares of Common Stock may be issued in
compliance with such limitation, but in no event later than the Expiration Date.


 


(c) The provisions of this Section 14 shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 14 to correct this
Section 14 (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.]1


 


15. Miscellaneous.


 


(a) Subject to the restrictions on transfer
set forth on the first page hereof, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company
except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on the parties hereto and their
respective successors and assigns. This Warrant shall be for the sole and exclusive benefit of the Holder of this Warrant and nothing
in this Warrant shall be construed to confer upon any person other than the Holder of this Warrant any legal or equitable right,
remedy or claim hereunder.


 





 






1
ONLY WITH RESPECT TO NEA.


 




    	9



    	 



    

 


(b) The Company will not, by amendment of
its governing documents or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the Holder against impairment. Without limiting the generality of the
foregoing, the Company (i) will not increase the par value of any Warrant Shares above the amount payable therefor on such
exercise, (ii) will take all such action as may be reasonably necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares on the exercise of this Warrant, and (iii) will not close its
stockholder books or records in any manner which interferes with the timely exercise of this Warrant.


 


(c) Nothing contained in this Warrant shall
be construed as imposing any liabilities on the Holder as a stockholder of the Company, whether such liabilities are asserted by
the Company or by creditors of the Company. Until the exercise of this Warrant, the Holder shall not have nor exercise any rights
by virtue hereof as a stockholder of the Company. Notwithstanding the foregoing, in the event (a) the Company effects a split
of the Common Stock by means of a stock dividend and the Exercise Price of and the number of Shares are adjusted as of the date
of the distribution of the dividend (rather than as of the record date for such dividend), and (b) the Holder exercises this
Warrant between the record date and the distribution date for such stock dividend, the Holder shall be entitled to receive, on
the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such exercise, notwithstanding
the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.


 


(d) All questions concerning the construction,
validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the
laws of the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the city of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the transaction
documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, or that such suit, action or proceeding is improper. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under Section 12 hereof and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. The Company hereby waives all rights to a trial by jury.


 


(e) The headings herein are for convenience
only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.


 


(f) In case any one or more of the provisions
of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions
of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a
valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Warrant.


 


(g)No amendment, modification or other
change to, or waiver of any provision of, this Warrant may be made unless such amendment, modification or change is (i) set forth
in writing and is signed by the Company and (ii) agreed to in writing by the holders of Warrants exercisable for a majority of
the number of shares into which the all of the then outstanding Warrants issued pursuant to the Purchase Agreement are exercisable
(without regard to any limitation contained herein on such exercise), it being understood that upon the satisfaction of the conditions
described in (i) and (ii) above, each Warrant (including any Warrant held by the Holder who did not execute the agreement specified
in (ii) above) shall be deemed to incorporate any amendment, modification, change or waiver effected thereby as of the effective
date thereof.


 


SIGNATURE PAGE FOLLOWS


 




    	10



    	 



    

 


IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly executed by its authorized officer as of the date first indicated above.


 


 


	 	 	 	 
	 	CHAMPIONS ONCOLOGY, INC.
	 	 	 
	 	By:	 	
        /s/ Joel Ackerman 

	 	Name:	 	
         Joel
        Ackerman

	 	Title:	 	
         Chief
        Executive Officer



 




    	11



    	 



    

 


EXHIBIT A


 


TRANSFER NOTICE


 


[To be completed and signed only upon transfer
of Warrant]


 


FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto                     
the right represented by the within Warrant to purchase                     
shares of Common Stock of Champions Oncology, Inc. to which the within Warrant relates and appoints                     
attorney to transfer said right on the books of Champions Oncology, Inc. with full power of substitution in the premises.


 





	Dated:                     ,         	 	 
	 	 	 
	 	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 	 
	 	 	 
	 	 	 
	 	 	Address of Transferee
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Taxpayer Identification Number







 


 




    	 



    	 



    

 


EXHIBIT B 


 


(To be executed by the Holder to exercise the
right to purchase shares of


 


Common Stock under the foregoing Warrant)


 


To Champions Oncology, Inc.:


 


The undersigned is the Holder of Warrant No.             
(the “Warrant”) issued by Champions Oncology, Inc., a Delaware corporation (the “Company”).
[The undersigned Holder acknowledges that the sale, transfer, assignment or hypothecation of the Warrant Shares to be issued upon
exercise of this Warrant is subject to the terms and conditions contained in Section 14 of this Warrant.]2
Capitalized terms used herein and not otherwise defined have the respective meanings set forth in the Warrant.


 





	1.	The Warrant is currently exercisable to purchase a total of                      Warrant Shares.


 


	2.	The undersigned Holder hereby exercises its right to purchase                      Warrant Shares pursuant to the Warrant.


 


	3.	The Holder intends that payment of the Exercise Price shall be made as (check one):


 


            
“Cash Exercise” under Section 10      


 


            
“Cashless Exercise” under Section 10


 


	4.	If the holder has elected a Cash Exercise, the holder shall pay the sum of $         to the Company in accordance with the terms of the Warrant.


 


	5.	Pursuant to this exercise, the Company shall deliver to the holder                      Warrant Shares in accordance with the terms of the Warrant.


 


	6.	Following this exercise, the Warrant shall be exercisable to purchase a total of                      Warrant Shares.


 


 






2 Include in NEA warrant only.


 




    	 



    	 



    

 





	Dated:                      ,             	 	Name of Holder:
	 	 	(Print)  	 
	 	 	By:  	 
	 	 	Name:  	 
	 	 	Title:  	 







 





	 	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 	 
	 	 	Taxpayer Identification Number
	 	 	 
	
        ACKNOWLEDGED AND AGREED TO this      day
        of             , 20     
	 	 
	 	 	 
	CHAMPIONS ONCOLOGY, INC.	 	 
	 	 	 
	By:  	 	 	 
	Name:  	 	 	 
	Title: